secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001193125-25-272286
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics raises ~$93.3M net in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 8,385,809 shares at $10.51/share and 1,128,949 pre-funded warrants at $10.5099 each.
- Net proceeds approximately $93.3M after underwriting discounts and estimated expenses.
- Offering closed on November 7, 2025; insiders subject to lock-up until January 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/0001193125-25-272286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/d89818d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-272286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer